Fundraising FoxMana Ventures — 2019 Investments
5 investments dated 2019 · listed companies and verified rows first · show all
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)GaingelsLifespan Vision Ventures+4 more
__Twitter.png)
San Francisco, US
Catherine Planey(Executive Officer, Director)Alexander Mok(Executive Officer, Director)
BoardFrancisco Gimenez(Director)in
Co-investorsBoxGroupGaingelsNat Turner8VCAllen & CompanyViking Global+1 more
Nanotronics develops technology for manufacturing, positioning customers to gain an edge in production processes.
Advanced ManufacturingAI & Machine LearningDeep TechHardwareSemiconductorsBrooklyn, US
John Putman(Founder)inMatthew Putman(Founder)in
BoardPeter Thiel(Director)in
Co-investorsFounders FundMetaplanetOrbiMedInvestment Corporation of Dubai (ICD)
Wildtype grows salmon directly from fish cells using cellular agriculture, allowing production of seafood without wild-caught or farmed fish.
BiotechClimate TechFoodTechSan Francisco, US
Justin Kolbeck(Founder)inArye Elfenbein(Founder)inJustin Kolbeck Arye Elfenbein(Founder)
.jpg)
BoardJohn Melas-Kyriazi(Director)
Co-investorsBay Bridge Ventures ClimateCRV (Charles River Ventures)Maven VenturesMission BiocapitalRedefine Ventures LlcRoot Ventures Manager, Llc+20 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.